Thailand Functional Mushroom & Specialty Fungi 2027 Market Intelligence
Thai specialty mushroom and functional-fungi category scales from THB 0.4-0.9B (2024) to a THB 6-11B receipt pool by 2027 on Lion's Mane, Reishi, Cordyceps cultivation at Hi Mushroom, Cordy Thailand, Phitsanulok Reishi, Doi Tung and Mae Fah Luang Foundation, with Sappe, BUR, Vata, Mansome RTD off-take and Bumrungrad VitalLife, BDMS Wellness longevity-clinic protocol demand.
Key takeaways
- 1
Thai specialty mushroom and functional-fungi receipts scale from an estimated in 2024 to a pool by 2027, an 8-14x expansion built on Lion's Mane, Reishi, Cordyceps militaris, Turkey Tail, Chaga and premium Shiitake cultivation off Chiang Mai, Mae Hong Son altitude, Chumphon humidity and Phitsanulok temperate-belt grow rooms.
- 2
Operator anchors: Hi Mushroom Thailand (Chiang Mai Lion's Mane and Reishi), Cordy Thailand (Lampang Cordyceps militaris extract), Mae Fah Luang Foundation Highland Mushroom Programme and Doi Tung brand, Phitsanulok Reishi Cooperative aggregating ~40 smallholders, plus the Thai Functional Mushroom Cooperative national network.
- 3
Functional-beverage off-take from Sappe Mushroom Tea (SET: SAPPE), BUR Mushroom Latte, Vata Mushroom Tonic and Mansome Cordy pulls Thai-grown powder into 7-Eleven and specialty retail; longevity-clinic protocols at Bumrungrad VitalLife, BDMS Wellness Clinic and Banyan Tree Wellness absorb premium dried supply at per cycle.
- 4
2027 policy stack: TFDA Functional Mushroom Health Claim framework targeted Q3 2026 effective date enables on-pack cognitive, immune and stress-relief claims; BOI Section 8 specialty-agriculture incentives extended Q2 2025 grant 5-8 year tax holiday on cultivation and extract processing capex.
- 5
Export demand to Korea (Hyperion Wellness), Japan (premium functional-tea brands) and the US (Four Sigmatic, MUD/WTR sourcing competitive set) clears at per kilogramme dried, framing Thai-grown product as a cost-competitive premium tier against Chinese-origin commodity supply.
Executive summary
Thailand's specialty mushroom and functional-fungi category captured an estimated in 2024 receipts across cultivation, dried whole, extract powder, functional-beverage off-take, longevity-clinic protocol supply and export. Insight reconciles the range by triangulating Mordor Intelligence's Thai functional food and beverage outlook (which sizes the broader functional category at in 2024 and attributes 1.5-3 percent to specialty mushroom formats), SCB EIC's wellness tourism and longevity-clinic flow (which captures supplementation cycles at each), and BIOTEC plus Mae Fah Luang Foundation operator-level disclosures. The 2027 forecast lands at , an 8-14x receipt expansion that is operator-led rather than consumer-pull-only.[, , , ]
Cultivation supply concentrates across three geographic belts. The Chiang Mai and Mae Hong Son altitude belt (800- elevation) anchors Lion's Mane and Reishi grow rooms operated by Hi Mushroom Thailand, the Mae Fah Luang Foundation Highland Mushroom Programme and a cluster of independent boutique cultivators. The Chumphon humidity belt and Phitsanulok temperate cluster support Reishi Cooperative production aggregating ~40 smallholder growers. Lampang and Chiang Mai controlled-environment grow rooms anchor Cordyceps militaris and cordycepin extract output at Cordy Thailand. BIOTEC strain library standardisation, Royal Project R&D and Department of Agriculture research-station spawn distribution underwrite cultivar quality and yield improvement.[, , , , , ]
Demand splits across four channels. Functional-beverage off-take pulls dried powder into RTD formats at Sappe Mushroom Tea (a SET-listed SAPPE innovation pipeline SKU), BUR Mushroom Latte, Vata Mushroom Tonic and Mansome Cordy. Longevity-clinic protocol supply at Bumrungrad VitalLife, BDMS Wellness Clinic and Banyan Tree Wellness absorbs premium dried Reishi and Lion's Mane at per cycle. Supplement and capsule manufacturing supplies the per capsule SKU tier across Watsons, Boots and ecommerce. Korea, Japan and US export at per kilogramme dried captures the remainder. The 2027 thesis pulls all four channels into a coherent receipt pool: cultivation scales because off-take demand is contractual, and off-take demand scales because the TFDA Functional Mushroom Health Claim framework legitimises on-pack cognitive, immune and stress-relief language for the first time.[, , , , , ]
Thai specialty mushroom and functional-fungi receipts (THB billion, 2024-2027F)
2024
Receipts (THB B)
0.7
Context
Pre-thesis baseline; cultivation fragmented; export sliver only
2025
Receipts (THB B)
1.6
Context
BOI Section 8 extension Q2 2025; Hi Mushroom and Cordy Thailand capacity ramp
2026E
Receipts (THB B)
3.2
Context
Sappe Mushroom Tea launch; longevity-clinic protocols formalise
2027F
Receipts (THB B)
8.4
Context
Base case mid-point of $0.174-11B band; TFDA health claim live; export scales
| Year | Receipts (THB B) | Context |
|---|---|---|
| 2024 | 0.7 | Pre-thesis baseline; cultivation fragmented; export sliver only |
| 2025 | 1.6 | BOI Section 8 extension Q2 2025; Hi Mushroom and Cordy Thailand capacity ramp |
| 2026E | 3.2 | Sappe Mushroom Tea launch; longevity-clinic protocols formalise |
| 2027F | 8.4 | Base case mid-point of $0.174-11B band; TFDA health claim live; export scales |
Species mix by share of 2026E receipts
Lion's Mane (Hericium erinaceus)
Share %
Notes
Cognitive-support anchor; Hi Mushroom and Chiang Mai cluster lead
Reishi (Ganoderma lucidum)
Share %
Notes
Immune and stress anchor; Phitsanulok Cooperative and Doi Tung lead
Cordyceps militaris
Share %
Notes
Energy and recovery; Cordy Thailand Lampang cultivation; cordycepin extract
Premium Shiitake (Lentinula edodes)
Share %
Notes
Foodservice and Doi Tung retail; less functional-claim driven
Turkey Tail (Trametes versicolor)
Share %
9%
Notes
Immune-support niche; PSK and PSP polysaccharide claim path
Chaga (Inonotus obliquus) and other
Share %
9%
Notes
Imported and small cultivated; antioxidant niche
| Species | Share % | Notes |
|---|---|---|
| Lion's Mane (Hericium erinaceus) | 28% | Cognitive-support anchor; Hi Mushroom and Chiang Mai cluster lead |
| Reishi (Ganoderma lucidum) | 22% | Immune and stress anchor; Phitsanulok Cooperative and Doi Tung lead |
| Cordyceps militaris | 18% | Energy and recovery; Cordy Thailand Lampang cultivation; cordycepin extract |
| Premium Shiitake (Lentinula edodes) | 14% | Foodservice and Doi Tung retail; less functional-claim driven |
| Turkey Tail (Trametes versicolor) | 9% | Immune-support niche; PSK and PSP polysaccharide claim path |
| Chaga (Inonotus obliquus) and other | 9% | Imported and small cultivated; antioxidant niche |
Analyst framing
Why this report
Unlock the full report
Need more than the web report? Ask for a scoped export or source appendix.
Every report keeps visible citations and source metadata. Terms.
Key figures
Selected anchors from the report evidence pack.
Thailand specialty mushroom and functional-fungi receipts (2024-2027F)
BIOTEC Mushroom Research Unit, Mordor Intelligence Thai functional food and beverage outlook, SCB EIC Wellness Tourism and Longevity Clinic Outlook 2026, operator disclosures
Thailand specialty mushroom species mix (2026E share of receipts)
BIOTEC Mushroom Research Unit, Mordor Intelligence, operator disclosures, Insight derivation
Thailand specialty mushroom operator concentration (2026E)
BIOTEC, Mae Fah Luang Foundation, Sappe 56-1, operator disclosures, Insight derivation
Thai specialty mushroom dried ASP per kilogramme by species and channel (2026)
Hi Mushroom Thailand, Cordy Thailand, Korea Customs Service, MoC DITP, Bumrungrad VitalLife disclosures
Thai specialty mushroom cultivation cost per kilogramme dried (2026)
BIOTEC Mushroom Research Unit, DoA mushroom research stations, Hi Mushroom Thailand, Cordy Thailand, operator disclosures
Thailand specialty mushroom export destinations (2025-2026 cumulative)
MoC DITP functional-food export, Korea Customs Service, Yano Research Institute, Nutrition Business Journal
TFDA Functional Mushroom Health Claim framework timeline (2026-2027)
TFDA Functional Mushroom Health Claim consultation paper
Thai longevity-clinic mushroom protocol pricing (2026)
Bumrungrad VitalLife Centre, BDMS Wellness Clinic, SCB EIC Wellness Tourism and Longevity Clinic Outlook 2026
Related reports
Thailand Anti-Aging & Longevity Clinics 2027 Market Intelligence
Thailand is repositioning premium medical tourism away from cosmetic surgery, IVF and dental toward longevity-medicine clinics: rapamycin and metformin off-label protocols, NAD+ IV infusions, peptide therapeutics (BPC-157, CJC-1295), hyperbaric oxygen, therapeutic plasma exchange, full-genome and biological-age testing, and senolytics. The 2026 to 2027 catalyst stack includes the Bumrungrad VitalLife Wellness flagship, BDMS Bangkok Hospital Longevity Center, Samitivej Sukhumvit Longevity Wing and BNH Wellness Center; the Thai FDA Q1 2027 framework registering compounding pharmacies and off-label-by-protocol clinical use; the BOI Section 8 medical-tourism premium tier covering longevity equipment imports at 0 percent duty; the Phuket Wellness Resort cluster (Banyan Tree, Aman, Six Senses) adding 14-day longevity retreats at USD 35,000 to 65,000; the Genomics Thailand 50,000-person whole-genome cohort; and the cultural mainstreaming via Brian Johnson Blueprint, David Sinclair Tribe and Andrew Huberman. Our read: the 2027 Thai longevity-medicine market reaches USD 0.8 to 1.5 billion (vs USD 0.18 to 0.3 billion in 2024), with Bumrungrad VitalLife, BDMS Longevity, Samitivej, BNH plus the Banyan Tree, Aman and Six Senses retreat resorts capturing roughly 70 percent share, and a long tail of independent boutique wellness clinics taking the remainder.
Open report β
Thailand Cold-Pressed Juice & Functional Beverage 2027 Market Intelligence
Thailand's health and wellness beverage category generated an estimated THB 95-105B in 2026, anchored by Osotspa's 37 percent functional and 54.8 percent energy share, Carabao Group's carbonated vitamin line (up 26 percent YoY in 2024), TC Pharmaceutical's Sponsor (73.5 percent sports-drink share) and Yanhee's 32 percent vitamin-water lead, with an emerging premium tier of cold-pressed HPP juice (Fresher Kitchen Beep, License To Blend, MyJuiceBkk), kombucha (Fermenthe), and fortified plant-milk (Lactasoy, Dutch Mill). The 2027 thesis: sugar tax phase four (2025), the national 90 percent low-sugar consumer target by 2027, and the June 2025 cannabis recontrol together force the category from energy-drink mass into clean-label premium where HPP juice, probiotic and adaptogen formats earn structurally higher margins.
Open report β
Thailand Non-Alcoholic & Functional Beverage 2027 Market Intelligence
Thailand's sober-curious wave (Gen Z 18-24 alcohol abstainer rate at 38 percent in 2024, up from 23 percent in 2019) meets the 3.2 million diagnosed diabetics and 40.7 percent adult-overweight public-health driver. The 2026-2027 catalyst stack: Excise Department sin-tax pivot (alcohol +6 percent, sugar-sweetened beverage Tier 5 effective April 2027); Boon Rawd (Singha Zero), Thai Beverage (Chang Beer Cheers Zero) and Carlsberg Thailand alcohol-free beer launches; Thai FDA Functional Beverage Health Claim framework; HoReCa mocktail share at Asia 50 Best Bangkok bars reaching 30 to 40 percent of cocktail revenue; Lyre's, Seedlip and Heineken 0.0 premium on-trade rollouts. Our read: the 2027 Thai non-alcoholic and functional beverage market reaches THB 28 to 44 billion (vs THB 14 to 19 billion in 2024), with Boon Rawd, ThaiBev, Sappe (SET:SAPPE) and CP Group (Mansome) capturing about 60 percent share.
Open report β
Thailand Specialty Tea Bubble Boba Premium Beverage 2027 Market Intelligence
Thailand's bubble-tea segment has matured from teen fad into mainstream THB 24-32B specialty-beverage category spanning 6,500-9,200 storefronts as of 2024. The 2027 inflection mixes Chinese tea-giant entry (Mixue at 800+ Thai outlets, Heytea, Naixue, Chagee combined USD 0.4-0.8B Thai capex 2024-2026), Thai heritage scaling (Cha Tra Mue, Brown Cafe), single-origin third-wave pivot (Doi Tung, Chiang Rai, Mae Salong at USD 35-95/kg export ASP versus USD 8-22/kg commodity), 25-45% CAGR functional-tea growth (kombucha 2.0, adaptogen, CBD, mushroom), and the Excise Sugar Tax Tier 5 (April 2027) that structurally rewards less-sugar premium positioning. Report maps operators, unit economics, regulation, and scenarios to 2031.
Open report β